Drug Farm Funding, Investors & Competitors

Drug Farm has raised $138M across 3 funding rounds, most recently a $55M Series D in July 2026.

Last Drug Farm funding round

$55M

Series D · Jul 2026

Cumulative funding Drug Farm raised

$138M

across 3 funding rounds

Key investors in Drug Farm

  • DT Capital Partners
  • BVCF
  • Wedo Venture Partners
  • Betta Capital
  • YD Capital
  • Wuxi AppTec
  • South China Venture Capital
  • Bull Capital

Drug Farm Overview

About Drug Farm

Drug Farm is a U.S.- and China-based biotechnology company engineering gene therapies for HBV, liver cancer, and autoimmune disorders via its IDInVivo platform integrating CRISPR screens and AI-driven target discovery. Headquartered in San Francisco with R&D in Shanghai, it raised $20 million in Series A funding in 2022 from Arch Venture Partners. Drug Farm's DF-001 targets HBV cccDNA clearance, entering IND-enabling studies, while DF-002 addresses PD-1 resistant tumors. The firm collaborates with WuXi AppTec for manufacturing.


Founded

2015

HQ

ChinaShanghai

Status

Privately held

Customer focus

B2B

Revenue model

Licensing, Subscription

Drug Farm Funding History

Drug Farm has raised a total of $138M across 3 funding rounds.

Drug Farm's first fundraising round was a $56M Series A in February 2021. The most recent completed round was a $55M Series D in July 2026.

Drug Farm funding rounds

Drug Farm funding rounds
DateStageInvestorsRaisedDeal Summary
Jul 2026Series DCaolu Investment (lead); Chuanghe (Shanghai) Private Equity Investment Fund (lead); Shenzhen Guoxin Yihe Emerging Industry Private Equity; BVCF; Bull Capital; DT Capital Partners; Betta Capital; YD Capital; Huzhou Talent Innovation Equity Investment Fund Partnership; Wedo Venture Partners; Keyuan Pharmaceutical; Yishan Jiabao Investment$55M-
May 2023Series CYD Capital (lead); DT Capital Partners; Betta Capital; Jiashan County State-owned Assets Investment; Wedo Venture Partners$27MDrug Farm, a biopharma company, raised $27 million in a financing round around May 16, 2023, led by YD Capital, with participation from new investors including Jiashan County State-owned Assets Investment, Betta Capital, and existing investors such as DT Capital Partners and Wedo Venture Partners. Drug Farm has announced developments like FDA acceptance of its candidate DF-003 into a rare disease program, indicating focus on drug development in areas such as rare diseases.
Feb 2021Series AWuxi AppTec; South China Venture Capital; BVCF; DT Capital Partners; Zuig Investment$56M-

Who has invested in Drug Farm?

16 investors have backed Drug Farm across its funding rounds, including DT Capital Partners, BVCF, Wedo Venture Partners, Betta Capital, YD Capital and Wuxi AppTec.

Lead investors include Caolu Investment, Chuanghe (Shanghai) Private Equity Investment Fund and YD Capital.


Drug Farm Investors

Investors in Drug Farm by funding rounds participated
InvestorHQRoundsRoleFirst check
DT Capital PartnersChinaChina3ParticipantFeb 2021
BVCFChinaShanghai2ParticipantFeb 2021
Betta Capital--2ParticipantMay 2023
YD CapitalCzech RepublicPrague2LeadMay 2023
Wedo Venture PartnersSingaporeSingapore2ParticipantMay 2023
Shenzhen Guoxin Yihe Emerging Industry Private EquityChinaShenzhen1ParticipantJul 2026
Wuxi AppTecChinaShanghai1ParticipantFeb 2021
South China Venture CapitalChinaShenzhen1ParticipantFeb 2021
Caolu InvestmentChinaShanghai1LeadJul 2026
Bull CapitalCayman IslandsGeorge Town1ParticipantJul 2026
Zuig InvestmentChinaHangzhou1ParticipantFeb 2021
Chuanghe (Shanghai) Private Equity Investment FundChinaShanghai1LeadJul 2026
Jiashan County State-owned Assets InvestmentChinaChina1ParticipantMay 2023

This data is available for Pro users. Sign up to see all 16 Drug Farm investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Investments by Drug Farm

Drug Farm has invested in 1 company to date.

Latest investment by Drug Farm was on August 23rd 2021. Drug Farm invested in NeuroDawn Pharmaceutical in their $11M Series A round.


Latest Investments by Drug Farm

NeuroDawn Pharmaceutical
Description
NeuroDawn Pharmaceutical is a biopharmaceutical firm that designs novel therapeutics for central nervous system diseases. Its pipeline targets neurological conditions through small molecule inhibitors and modulators that address underlying disease mechanisms. Based in China, the company conducts research in Shanghai and collaborates with local institutions for preclinical and clinical development stages.
HQ CountryChina
HQ City
Nanjing
Deal Date23 Aug 2021
RoundSeries A
Raised$11M
InvestorsDynamic Balance Capital; Simcere Pharmaceutical Group
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Drug Farm investments and their VC round multiples.

Start Free Trial

Drug Farm Competitors

Drug Farm competitors include listed companies like SAP and Snowflake, and private ones like Astromech, Chai Discovery, Anthropic and OpenAI.

Public and private companies comparable to Drug Farm
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
AstromechUnited StatesUnited StatesPrivate--$3.8B-
Chai DiscoveryUnited StatesSan Francisco, CAPrivate$48M-$3.8B-
AnthropicUnited StatesSan Francisco, CAPrivate$47B-$965B20.5x
OpenAIUnited StatesSan Francisco, CAPrivate$25B-$852B34.1x
SAPGermanyGermanyPublicly listed$42B$13B$248B5.4x
SnowflakeUnited StatesUnited StatesPublicly listed$4.7B($1.3B)$119B21.0x

Drug Farm Public Comps

Drug Farm is still privately-owned, but its public comps include Eli Lilly, Johnson & Johnson, AbbVie, Merck, Roche, Novartis, AstraZeneca, CrowdStrike, SAP and Amgen.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Eli Lilly$65B$28B16.5x13.1x38.7x27.0x
Johnson & Johnson$94B$40B7.2x6.8x17.0x18.3x
AbbVie$61B$17B8.7x8.1x30.6x17.6x
Merck$65B$28B6.3x6.2x14.7x21.0x
Roche$77B$26B5.0x4.9x14.6x12.4x
Novartis$57B$22B5.5x5.5x14.2x13.3x
AstraZeneca$59B$19B4.8x4.5x14.6x12.7x
CrowdStrike$4.8B($12M)51.4x44.5x(19816.2x)151.0x

This data is available for Pro users. Sign up to see all Drug Farm competitors and their valuation data.

Start Free Trial

Common questions about Drug Farm

When was Drug Farm founded?Drug Farm was founded in 2015.
Where is Drug Farm headquartered?Drug Farm is headquartered in Shanghai, China.
Is Drug Farm publicly listed?No, Drug Farm is a private, VC-backed company.
How much funding has Drug Farm raised?Drug Farm has raised $138M across 3 funding rounds.
What was Drug Farm's last funding round?Drug Farm's last funding round was a $55M Series D in July 2026, led by Caolu Investment and Chuanghe (Shanghai) Private Equity Investment Fund.
Who are Drug Farm's investors?Drug Farm's investors include DT Capital Partners, BVCF, Betta Capital, YD Capital, Wedo Venture Partners, Shenzhen Guoxin Yihe Emerging Industry Private Equity, Wuxi AppTec, South China Venture Capital, Caolu Investment, Bull Capital and 6 others.
Which companies are comparable to Drug Farm?Companies comparable to Drug Farm include Astromech, Chai Discovery, Anthropic, OpenAI, SAP and Snowflake.
How many companies has Drug Farm invested in?Drug Farm has invested in 1 company, including NeuroDawn Pharmaceutical.
What was Drug Farm's last investment?In August 2021, Drug Farm invested in NeuroDawn Pharmaceutical's $11M Series A alongside Dynamic Balance Capital and Simcere Pharmaceutical Group.

See companies similar to Drug Farm

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial